Long‐Term Outcome of Consecutive Patients With Previous Coronary Bypass Surgery, Treated With Newer‐Generation Drug‐Eluting Stents

BackgroundPercutaneous coronary intervention (PCI) in patients with previous coronary artery bypass grafting (CABG) is associated with adverse clinical events. Although newer generation drug‐eluting stents showed favorable short‐term safety profiles, there is a lack of long‐term outcome data. We eva...

Full description

Bibliographic Details
Main Authors: Liefke C. van der Heijden, Marlies M. Kok, Paolo Zocca, Hanim Sen, Marije M. Löwik, Silvia Mariani, Frits H. A. F. de Man, Marc Hartmann, Martin G. Stoel, K. Gert van Houwelingen, J. (Hans) W. Louwerenburg, Gerard C. M. Linssen, Carine J. M. Doggen, Jan G. Grandjean, Clemens von Birgelen
Format: Article
Language:English
Published: Wiley 2018-02-01
Series:Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Subjects:
Online Access:https://www.ahajournals.org/doi/10.1161/JAHA.117.007212
_version_ 1819178485857386496
author Liefke C. van der Heijden
Marlies M. Kok
Paolo Zocca
Hanim Sen
Marije M. Löwik
Silvia Mariani
Frits H. A. F. de Man
Marc Hartmann
Martin G. Stoel
K. Gert van Houwelingen
J. (Hans) W. Louwerenburg
Gerard C. M. Linssen
Carine J. M. Doggen
Jan G. Grandjean
Clemens von Birgelen
author_facet Liefke C. van der Heijden
Marlies M. Kok
Paolo Zocca
Hanim Sen
Marije M. Löwik
Silvia Mariani
Frits H. A. F. de Man
Marc Hartmann
Martin G. Stoel
K. Gert van Houwelingen
J. (Hans) W. Louwerenburg
Gerard C. M. Linssen
Carine J. M. Doggen
Jan G. Grandjean
Clemens von Birgelen
author_sort Liefke C. van der Heijden
collection DOAJ
description BackgroundPercutaneous coronary intervention (PCI) in patients with previous coronary artery bypass grafting (CABG) is associated with adverse clinical events. Although newer generation drug‐eluting stents showed favorable short‐term safety profiles, there is a lack of long‐term outcome data. We evaluated the impact of previous CABG on 5‐year clinical outcomes of patients treated with PCI using newer‐generation drug‐eluting stents. Methods and ResultsIn this patient‐level pooled analysis of the prospective TWENTE (The Real‐World Endeavor Resolute versus Xience V Drug‐Eluting Stent Study in Twente) trial and nonenrolled TWENTE registry, we assessed a consecutive series of patients who underwent PCI with newer‐generation drug‐eluting stents for non–ST‐segment–elevation acute coronary syndromes or stable angina. Of all 1709 patients, 202 (11.8%) had a history of CABG. Patients with previous CABG had significantly higher 5‐year rates of cardiac death (10.4% versus 4.3%; P<0.001) and target vessel revascularization (25.0% versus 8.1%; P<0.001). These differences remained statistically significant after adjustment for differences in baseline characteristics. Landmark analysis revealed that from 1‐ to 5‐year follow‐up, the rates of cardiac death (8.1% versus 3.2%; P<0.001) and target vessel revascularization (17.1% versus 5.9%; P<0.001) were significantly higher in patients with previous CABG. Among patients with a history of CABG, PCI of an obstructed vein graft was associated with a higher rate of 5‐year target vessel revascularization (P=0.003). ConclusionsAt 5‐year follow‐up after PCI with newer‐generation drug‐eluting stents, the risk of cardiac death and target vessel revascularization was significantly higher in patients with previous CABG. The target vessel revascularization rate was highest in patients who underwent PCI of obstructed vein grafts.
first_indexed 2024-12-22T21:43:18Z
format Article
id doaj.art-d4b839f1a07e48468123d10dda03d38a
institution Directory Open Access Journal
issn 2047-9980
language English
last_indexed 2024-12-22T21:43:18Z
publishDate 2018-02-01
publisher Wiley
record_format Article
series Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
spelling doaj.art-d4b839f1a07e48468123d10dda03d38a2022-12-21T18:11:34ZengWileyJournal of the American Heart Association: Cardiovascular and Cerebrovascular Disease2047-99802018-02-017310.1161/JAHA.117.007212Long‐Term Outcome of Consecutive Patients With Previous Coronary Bypass Surgery, Treated With Newer‐Generation Drug‐Eluting StentsLiefke C. van der Heijden0Marlies M. Kok1Paolo Zocca2Hanim Sen3Marije M. Löwik4Silvia Mariani5Frits H. A. F. de Man6Marc Hartmann7Martin G. Stoel8K. Gert van Houwelingen9J. (Hans) W. Louwerenburg10Gerard C. M. Linssen11Carine J. M. Doggen12Jan G. Grandjean13Clemens von Birgelen14Department of Cardiology, Thoraxcentrum Twente, Medisch Spectrum Twente, Enschede, the NetherlandsDepartment of Cardiology, Thoraxcentrum Twente, Medisch Spectrum Twente, Enschede, the NetherlandsDepartment of Cardiology, Thoraxcentrum Twente, Medisch Spectrum Twente, Enschede, the NetherlandsDepartment of Cardiology, Thoraxcentrum Twente, Medisch Spectrum Twente, Enschede, the NetherlandsDepartment of Cardiology, Thoraxcentrum Twente, Medisch Spectrum Twente, Enschede, the NetherlandsDepartment of Cardiothoracic Surgery, Thoraxcentrum Twente, Medisch Spectrum Twente, Enschede, the NetherlandsDepartment of Cardiology, Thoraxcentrum Twente, Medisch Spectrum Twente, Enschede, the NetherlandsDepartment of Cardiology, Thoraxcentrum Twente, Medisch Spectrum Twente, Enschede, the NetherlandsDepartment of Cardiology, Thoraxcentrum Twente, Medisch Spectrum Twente, Enschede, the NetherlandsDepartment of Cardiology, Thoraxcentrum Twente, Medisch Spectrum Twente, Enschede, the NetherlandsDepartment of Cardiology, Thoraxcentrum Twente, Medisch Spectrum Twente, Enschede, the NetherlandsDepartment of Cardiology, Ziekenhuisgroep Twente, Almelo and Hengelo, the NetherlandsDepartment of Health Technology and Services Research, MIRA—Institute for Biomedical Technology and Technical Medicine, University of Twente, Enschede, the NetherlandsDepartment of Cardiothoracic Surgery, Thoraxcentrum Twente, Medisch Spectrum Twente, Enschede, the NetherlandsDepartment of Cardiology, Thoraxcentrum Twente, Medisch Spectrum Twente, Enschede, the NetherlandsBackgroundPercutaneous coronary intervention (PCI) in patients with previous coronary artery bypass grafting (CABG) is associated with adverse clinical events. Although newer generation drug‐eluting stents showed favorable short‐term safety profiles, there is a lack of long‐term outcome data. We evaluated the impact of previous CABG on 5‐year clinical outcomes of patients treated with PCI using newer‐generation drug‐eluting stents. Methods and ResultsIn this patient‐level pooled analysis of the prospective TWENTE (The Real‐World Endeavor Resolute versus Xience V Drug‐Eluting Stent Study in Twente) trial and nonenrolled TWENTE registry, we assessed a consecutive series of patients who underwent PCI with newer‐generation drug‐eluting stents for non–ST‐segment–elevation acute coronary syndromes or stable angina. Of all 1709 patients, 202 (11.8%) had a history of CABG. Patients with previous CABG had significantly higher 5‐year rates of cardiac death (10.4% versus 4.3%; P<0.001) and target vessel revascularization (25.0% versus 8.1%; P<0.001). These differences remained statistically significant after adjustment for differences in baseline characteristics. Landmark analysis revealed that from 1‐ to 5‐year follow‐up, the rates of cardiac death (8.1% versus 3.2%; P<0.001) and target vessel revascularization (17.1% versus 5.9%; P<0.001) were significantly higher in patients with previous CABG. Among patients with a history of CABG, PCI of an obstructed vein graft was associated with a higher rate of 5‐year target vessel revascularization (P=0.003). ConclusionsAt 5‐year follow‐up after PCI with newer‐generation drug‐eluting stents, the risk of cardiac death and target vessel revascularization was significantly higher in patients with previous CABG. The target vessel revascularization rate was highest in patients who underwent PCI of obstructed vein grafts.https://www.ahajournals.org/doi/10.1161/JAHA.117.007212coronary artery bypass graftdrug‐eluting stentpercutaneous coronary interventionResoluteXience V
spellingShingle Liefke C. van der Heijden
Marlies M. Kok
Paolo Zocca
Hanim Sen
Marije M. Löwik
Silvia Mariani
Frits H. A. F. de Man
Marc Hartmann
Martin G. Stoel
K. Gert van Houwelingen
J. (Hans) W. Louwerenburg
Gerard C. M. Linssen
Carine J. M. Doggen
Jan G. Grandjean
Clemens von Birgelen
Long‐Term Outcome of Consecutive Patients With Previous Coronary Bypass Surgery, Treated With Newer‐Generation Drug‐Eluting Stents
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
coronary artery bypass graft
drug‐eluting stent
percutaneous coronary intervention
Resolute
Xience V
title Long‐Term Outcome of Consecutive Patients With Previous Coronary Bypass Surgery, Treated With Newer‐Generation Drug‐Eluting Stents
title_full Long‐Term Outcome of Consecutive Patients With Previous Coronary Bypass Surgery, Treated With Newer‐Generation Drug‐Eluting Stents
title_fullStr Long‐Term Outcome of Consecutive Patients With Previous Coronary Bypass Surgery, Treated With Newer‐Generation Drug‐Eluting Stents
title_full_unstemmed Long‐Term Outcome of Consecutive Patients With Previous Coronary Bypass Surgery, Treated With Newer‐Generation Drug‐Eluting Stents
title_short Long‐Term Outcome of Consecutive Patients With Previous Coronary Bypass Surgery, Treated With Newer‐Generation Drug‐Eluting Stents
title_sort long term outcome of consecutive patients with previous coronary bypass surgery treated with newer generation drug eluting stents
topic coronary artery bypass graft
drug‐eluting stent
percutaneous coronary intervention
Resolute
Xience V
url https://www.ahajournals.org/doi/10.1161/JAHA.117.007212
work_keys_str_mv AT liefkecvanderheijden longtermoutcomeofconsecutivepatientswithpreviouscoronarybypasssurgerytreatedwithnewergenerationdrugelutingstents
AT marliesmkok longtermoutcomeofconsecutivepatientswithpreviouscoronarybypasssurgerytreatedwithnewergenerationdrugelutingstents
AT paolozocca longtermoutcomeofconsecutivepatientswithpreviouscoronarybypasssurgerytreatedwithnewergenerationdrugelutingstents
AT hanimsen longtermoutcomeofconsecutivepatientswithpreviouscoronarybypasssurgerytreatedwithnewergenerationdrugelutingstents
AT marijemlowik longtermoutcomeofconsecutivepatientswithpreviouscoronarybypasssurgerytreatedwithnewergenerationdrugelutingstents
AT silviamariani longtermoutcomeofconsecutivepatientswithpreviouscoronarybypasssurgerytreatedwithnewergenerationdrugelutingstents
AT fritshafdeman longtermoutcomeofconsecutivepatientswithpreviouscoronarybypasssurgerytreatedwithnewergenerationdrugelutingstents
AT marchartmann longtermoutcomeofconsecutivepatientswithpreviouscoronarybypasssurgerytreatedwithnewergenerationdrugelutingstents
AT martingstoel longtermoutcomeofconsecutivepatientswithpreviouscoronarybypasssurgerytreatedwithnewergenerationdrugelutingstents
AT kgertvanhouwelingen longtermoutcomeofconsecutivepatientswithpreviouscoronarybypasssurgerytreatedwithnewergenerationdrugelutingstents
AT jhanswlouwerenburg longtermoutcomeofconsecutivepatientswithpreviouscoronarybypasssurgerytreatedwithnewergenerationdrugelutingstents
AT gerardcmlinssen longtermoutcomeofconsecutivepatientswithpreviouscoronarybypasssurgerytreatedwithnewergenerationdrugelutingstents
AT carinejmdoggen longtermoutcomeofconsecutivepatientswithpreviouscoronarybypasssurgerytreatedwithnewergenerationdrugelutingstents
AT janggrandjean longtermoutcomeofconsecutivepatientswithpreviouscoronarybypasssurgerytreatedwithnewergenerationdrugelutingstents
AT clemensvonbirgelen longtermoutcomeofconsecutivepatientswithpreviouscoronarybypasssurgerytreatedwithnewergenerationdrugelutingstents